Civic IQ
SUPPLIESRECOMMENDED

American Academy of Family Physicians Immunization Schedule 2025

AstraZeneca's Beyfortus Included for RSV Immunization

Prince William County Public SchoolsASTRAZENECAJanuary 1, 2025

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

AstraZeneca's co-manufactured Beyfortus monoclonal antibody is recommended for use in the 2025–2026 RSV immunization schedule for pediatric patients. Providers are directed to utilize any available authorized RSV-mAb product.

Contract Details

Vendor

ASTRAZENECA

Agency

Prince William County Public Schools, VA

Contract Type

SUPPLIES

Document Date

January 1, 2025

Contract Term

2025-2026 RSV season

Renewal Date

2026-03-31

Renewal Info

Coverage updated annually based on RSV season recommendations.

Bring us your territory.
We'll show you what is forming.

See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.

Try Civic IQ for free